{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:02:25Z","timestamp":1792634545919,"version":"4.5.0"},"reference-count":317,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005709","name":"Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preexisting diabetes (PDM) increases the risk of maternal and perinatal mortality and morbidity. Reduction of maternal hyperglycemia prior to and during pregnancy can reduce these risks. Despite compelling evidence that preconception care (PCC), which includes achieving strict glycemic goals, reduces the risk of congenital malformations and other adverse pregnancy outcomes, only a minority of individuals receive PCC. Suboptimal pregnancy outcomes demonstrated in real-world data highlight the need to further optimize prenatal glycemia. New evolving technology shows promise in helping to achieve that goal. Dysglycemia is not the only driver of poor pregnancy outcomes in PDM. The increasing impact of obesity on pregnancy outcomes underscores the importance of optimal nutrition and management of insulin sensitizing medications during prenatal care for PDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide recommendations for the care of individuals with PDM that lead to a reduction in maternal and neonatal adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Guideline Development Panel (GDP) composed of a multidisciplinary panel of clinical experts, along with experts in guideline methodology and systematic literature review, identified and prioritized 10 clinically relevant questions related to the care of individuals with diabetes before, during and after pregnancy. The GDP prioritized randomized controlled trials (RCTs) evaluating the effects of different interventions (eg, PCC, nutrition, treatment options, delivery) during the reproductive life cycle of individuals with diabetes, including type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Systematic reviews queried electronic databases for publications related to these 10 clinical questions. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was used to assess the certainty of evidence and develop recommendations. The approach incorporated perspectives from 2 patient representatives and considered patient values, costs and resources required, acceptability and feasibility, and impact on health equity of the proposed recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In individuals with diabetes mellitus who have the possibility of becoming pregnant, we suggest asking a screening question about pregnancy intention at every reproductive, diabetes, and primary care visit. Screening for pregnancy intent is also suggested at urgent care\/emergency room visits when clinically appropriate (2 | \u2295OOO). This was suggested based on indirect evidence demonstrating a strong association between PCC and both reduced glycated hemoglobin (HbA1c) at the first prenatal visit and congenital malformations.<\/jats:p>\n                    <jats:p>In individuals with diabetes mellitus who have the possibility of becoming pregnant, we suggest use of contraception when pregnancy is not desired (2 | \u2295\u2295OO). This was suggested based on indirect evidence in women with diabetes, where PCC\u2014including contraception as a key component\u2014showed a clinically significant association with improvements in first-trimester HbA1c and the rate of congenital malformations, together with indirect evidence from the general population regarding the reduction of unplanned pregnancies and pregnancy terminations with the use of contraception.<\/jats:p>\n                    <jats:p>In individuals with T2DM, we suggest discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RA) before conception rather than discontinuation between the start of pregnancy and the end of the first trimester (2 | \u2295OOO). This was suggested based on limited data on risk of exposure to GLP-1RA receptor agonists during pregnancy.<\/jats:p>\n                    <jats:p>In pregnant individuals with T2DM already on insulin, we suggest against routine addition of metformin (2 | \u2295OOO). This was suggested based on the GDP judgment that the benefit of adding metformin to insulin to achieve decrease in rates of large for gestational age infants did not outweigh the potential harm of increasing the risk of small for gestational age infants or adverse childhood outcomes related to changes in body composition.<\/jats:p>\n                    <jats:p>In individuals with PDM, we suggest either a carbohydrate-restricted diet (&amp;lt;175 g\/day) or usual diet (&amp;gt;175 g\/day) during pregnancy (2 | \u2295OOO). This was suggested based on the GDP judgment that the available evidence was limited and very indirect, resulting in significant uncertainty about the net benefits or harms. As such, the evidence was insufficient to support a recommendation either for or against a carbohydrate intake cutoff of 175 g\/day.<\/jats:p>\n                    <jats:p>In pregnant individuals with T2DM, we suggest either the use of a continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) (2 | \u2295OOO). There is lack of direct evidence supporting superiority of CGM use over SMBG for T2DM during pregnancy. There is indirect evidence supporting improved glucometrics with the use of CGM for individuals with T2DM outside of pregnancy, substantial improvements in neonatal outcomes for individuals with T1DM using CGM during pregnancy and the potential for decreasing adverse pregnancy outcomes with improved glucometrics in individuals with T2DM.<\/jats:p>\n                    <jats:p>In individuals with PDM using a CGM, we suggest against the use of a single 24-hour CGM target &amp;lt;140 mg\/dL (7.8 mmol\/L) in place of standard-of-care pregnancy glucose targets of fasting &amp;lt;95 mg\/dL (5.3 mmol\/L), 1-hour postprandial &amp;lt;140 mg\/dL (7.8 mmol\/L), and 2-hour postprandial &amp;lt; 120 mg\/dL (6.7 mmol\/L) (2 | \u2295OOO). This was suggested based on indirect evidence that associated adverse pregnancy outcomes with a fasting glucose &amp;gt; 126 mg\/dL (7 mmol\/L).<\/jats:p>\n                    <jats:p>In individuals with T1DM who are pregnant, we suggest the use of a hybrid closed-loop pump (pump adjusting automatically based on CGM) rather than an insulin pump with CGM (without an algorithm) or multiple daily insulin injections with CGM (2 | \u2295OOO). This was suggested based on a meta-analysis of RCTs which demonstrated improvement in glucometrics with increased time in range (MD +3.81%; CI \u22124.24 to 11.86) and reduced time below range (MD \u22120.88%; 95% CI: \u22122.04 to 0.27) with the use of hybrid closed-loop pump technology.<\/jats:p>\n                    <jats:p>In individuals with PDM, we suggest early delivery based on risk assessment rather than expectant management (2 | \u2295OOO). This was suggested based on indirect evidence that risks may outweigh benefits of expectant management beyond 38 weeks gestation and that risk assessment criteria may be useful to inform ideal delivery timing.<\/jats:p>\n                    <jats:p>In individuals with PDM (including those with pregnancy loss or termination), we suggest postpartum endocrine care (diabetes management), in addition to usual obstetric care (2 | \u2295OOO). As the postpartum period frequently overlaps with preconception, this was suggested based on indirect evidence demonstrating a strong association between PCC and both reduced HbA1c at the first prenatal visit and congenital malformations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data supporting these recommendations were of very low to low certainty, highlighting the urgent need for research designed to provide high certainty evidence to support the care of individuals with diabetes before, during, and after pregnancy. Investment in implementation science for PCC is crucial to prevent significant mortality and morbidity for individuals with PDM and their children. RCTs to further define glycemic targets in pregnancy and refinement of emerging technology to achieve those targets can lead to significant reduction of harm and in the burden of diabetes care. Data on optimal nutrition and obesity management in pregnancy are lacking. More research on timing of delivery in women with PDM is also needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf288","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:02:53Z","timestamp":1747209773000},"page":"2405-2452","source":"Crossref","is-referenced-by-count":52,"title":["Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-2137","authenticated-orcid":false,"given":"Jennifer A","family":"Wyckoff","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes\/Podiatry, Domino's Farms, University of Michigan , Lobby C, Suite 1300, 24 Frank Lloyd Wright Dr., PO Box 451, Ann Arbor, MI 48106-0451 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova , 35100 Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette D","family":"Asias-Dinh","sequence":"additional","affiliation":[{"name":"Pharmacy Practice and Translational Research, University of Houston , Houston, TX 77204-5000 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A","family":"Barbour","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, University of Colorado School of Medicine and Anschutz Medical Campus , 1635 N. Aurora Court, Aurora, CO 80045 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence M","family":"Brown","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center , One Joslin Place, Boston, MA 02215 ,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , 25 Shattuck St, Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Catalano","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital , 275 Cambridge Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Corcoy","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quint\u00ed, 08041 Barcelona ,","place":["Spain"]},{"name":"CIBER-BBN, Instituto de Salud Carlos III, Calle Monforte de Lemos , 3-5, 28029 Madrid ,","place":["Spain"]},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Pla\u00e7a C\u00edvica, 08193 Bellaterra ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Di Renzo","sequence":"additional","affiliation":[{"name":"PREIS International School , 50139 Firenze ,","place":["Italy"]},{"name":"Meyer Children's University Hospital , 50139 Firenze ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Drobycki","sequence":"additional","affiliation":[{"name":"Endocrinology Division, University of Texas Southwestern Medical Center of Dallas , Dallas, TX 75390 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-4105","authenticated-orcid":false,"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-Based Practice Center , Harwick Building, Room 2-54, Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Stephenson-Gray","sequence":"additional","affiliation":[{"name":"National Health Service , Cardiff ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-3936","authenticated-orcid":false,"given":"Adam G","family":"Tab\u00e1k","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology and Institute of Preventive Medicine and Public Health, Semmelweis University Faculty of Medicine, Semmelweis University of Medicine , H-1083 Budapest ,","place":["Hungary"]},{"name":"UCL Brain Sciences, University College London , London W1T 7NF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Weatherup","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes\/Podiatry, Domino's Farms, University of Michigan , Lobby C, Suite 1300, 24 Frank Lloyd Wright Dr., PO Box 451, Ann Arbor, MI 48106-0451 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Zera","sequence":"additional","affiliation":[{"name":"Obstetrics Gynecology & Reproductive Biology Department, Harvard Medical School, Shattuck St, Boston, MA 02115 ,","place":["USA"]},{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Beth Israel Deaconess Medical Center , 330 Brookline Ave, Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naykky","family":"Singh-Ospina","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Florida , PO Box 100226, Gainesville, FL 32610 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"key":"2025090312111623200_dgaf288-B1","doi-asserted-by":"publisher","first-page":"109049","DOI":"10.1016\/j.diabres.2021.109049","article-title":"IDF diabetes atlas: the prevalence of pre\u2013existing diabetes in pregnancy \u2013 a systematic review and meta\u2013analysis of studies published during 2010\u20132020","volume":"183","author":"Chivese","year":"2022","journal-title":"Diabetes Res Clin Pract."},{"issue":"7","key":"2025090312111623200_dgaf288-B2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/dmrr.2656","article-title":"Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy","volume":"31","author":"Jovanovi\u010d","year":"2015","journal-title":"Diabetes Metab Res Rev."},{"issue":"3","key":"2025090312111623200_dgaf288-B3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s2213-8587(20)30406-x","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"Suppl 1","key":"2025090312111623200_dgaf288-B4","first-page":"S306","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"8","key":"2025090312111623200_dgaf288-B5","doi-asserted-by":"crossref","first-page":"e0237571","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PLoS One"},{"issue":"10110","key":"2025090312111623200_dgaf288-B6","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"2025090312111623200_dgaf288-B7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/nu11081737","article-title":"Low-carbohydrate diets for gestational diabetes","volume":"11","author":"Farabi","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"2025090312111623200_dgaf288-B8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajog.2021.12.035","article-title":"The importance of nutrition in pregnancy and lactation: lifelong consequences","volume":"226","author":"Marshall","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.17925\/EE.2023.19.1.46","article-title":"Epigenetics of the pathogenesis and complications of type 2 diabetes mellitus","volume":"19","author":"Mannar","year":"2023","journal-title":"touchREV Endocrinol"},{"key":"2025090312111623200_dgaf288-B10","volume-title":"The GRADE Book (Version 1.0)","author":"Neumann","year":"2024"},{"issue":"22","key":"2025090312111623200_dgaf288-B11","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"2025090312111623200_dgaf288-B12","doi-asserted-by":"crossref","first-page":"166.e1","DOI":"10.1016\/j.gaceta.2017.02.010","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"32","author":"Alonso-Coello","year":"2018","journal-title":"Gac Sanit"},{"issue":"2","key":"2025090312111623200_dgaf288-B13","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.gaceta.2017.03.008","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines]","volume":"32","author":"Alonso-Coello","year":"2018","journal-title":"Gac Sanit"},{"key":"2025090312111623200_dgaf288-B14","year":"2024"},{"key":"2025090312111623200_dgaf288-B15","first-page":"e2811","article-title":"A systematic review supporting the clinical practice guidelines on the management of preexisting diabetes and pregnancy","volume-title":"J Clin Endocrinol Metab","author":"Al Nofal","year":"2025"},{"issue":"4","key":"2025090312111623200_dgaf288-B16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2025090312111623200_dgaf288-B17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"2025090312111623200_dgaf288-B18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jclinepi.2022.01.004","article-title":"Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines","volume":"146","author":"Piggott","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2025090312111623200_dgaf288-B19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"18","key":"2025090312111623200_dgaf288-B20","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med."},{"issue":"7","key":"2025090312111623200_dgaf288-B21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2337\/dc07-0278","article-title":"Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes","volume":"30","author":"Guerin","year":"2007","journal-title":"Diabetes Care"},{"issue":"4","key":"2025090312111623200_dgaf288-B22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(85)90083-3","article-title":"Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women","volume":"153","author":"Miodovnik","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2025090312111623200_dgaf288-B23","article-title":"Regional Office for South-East Asia","volume-title":"Preconception Care","author":"World Health Organization","year":"2014"},{"issue":"RR-6","key":"2025090312111623200_dgaf288-B24","first-page":"1","article-title":"Recommendations to improve preconception health and health care\u2014United States. A report of the CDC\/ATSDR preconception care work group and the select panel on preconception care","volume":"55","author":"Johnson","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"2025090312111623200_dgaf288-B25","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2337\/diacare.16.12.1572","article-title":"Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors","volume":"16","author":"James PJ","year":"1993","journal-title":"Diabetes Care"},{"issue":"6760","key":"2025090312111623200_dgaf288-B26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.301.6760.1070","article-title":"Can prepregnancy care of diabetic women reduce the risk of abnormal babies?","volume":"301","author":"Steel","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"2025090312111623200_dgaf288-B27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2013.05.003","article-title":"ONE KEY QUESTION\u00ae: preventive reproductive health is part of high quality primary care","volume":"88","author":"Bellanca","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"2025090312111623200_dgaf288-B28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.fertnstert.2018.12.003","article-title":"Prepregnancy counseling: committee opinion no. 762","volume":"111","author":"(ACOG) ASfRMAaACoO","year":"2019","journal-title":"Fertil Steril"},{"issue":"6","key":"2025090312111623200_dgaf288-B29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1370\/afm.1404","article-title":"Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial","volume":"10","author":"Schwarz","year":"2012","journal-title":"Ann Fam Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B30","doi-asserted-by":"crossref","first-page":"1698496","DOI":"10.1080\/17482631.2019.1698496","article-title":"The lived experiences of healthcare during pregnancy, birth, and three months after in women with type 1 diabetes mellitus","volume":"15","author":"Dahlberg","year":"2020","journal-title":"Int J Qual Stud Health Well-being"},{"issue":"8","key":"2025090312111623200_dgaf288-B31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/diacare.16.8.1146","article-title":"Cost-benefit analysis of preconception care for women with established diabetes mellitus","volume":"16","author":"Elixhauser","year":"1993","journal-title":"Diabetes Care"},{"issue":"4","key":"2025090312111623200_dgaf288-B32","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jc.2015-4046","article-title":"A prepregnancy care program for women with diabetes: effective and cost saving","volume":"101","author":"Egan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4-6","key":"2025090312111623200_dgaf288-B33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/07399332.2020.1817025","article-title":"Systematic review of economic evaluation studies on preconception care interventions","volume":"42","author":"Kotirum","year":"2021","journal-title":"Health Care Women Int"},{"issue":"1","key":"2025090312111623200_dgaf288-B34","doi-asserted-by":"crossref","first-page":"74.e1","DOI":"10.1016\/j.ajog.2014.09.009","article-title":"Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States","volume":"212","author":"Peterson","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2025090312111623200_dgaf288-B35","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"2025090312111623200_dgaf288-B36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/AOG.0000000000004659","article-title":"Patient-centered contraceptive counseling: ACOG committee statement number 1","volume":"139","author":"American College of Obstetricians and Gynecologists' Committee on Health Care for Underserved Women CEEWG, and Committee on Ethics","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2025090312111623200_dgaf288-B37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/fampra\/cmx086","article-title":"A systematic review of the effect of reproductive intention screening in primary care settings on reproductive health outcomes","volume":"35","author":"Burgess","year":"2018","journal-title":"Fam Pract"},{"issue":"2","key":"2025090312111623200_dgaf288-B38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/1475-6773.14123","article-title":"Preconception, interconception, and reproductive health screening tools: a systematic review","volume":"58","author":"Ren","year":"2023","journal-title":"Health Serv Res"},{"issue":"11","key":"2025090312111623200_dgaf288-B39","doi-asserted-by":"crossref","first-page":"e0206102","DOI":"10.1371\/journal.pone.0206102","article-title":"Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes","volume":"13","author":"Kohn","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"2025090312111623200_dgaf288-B40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/cd23-0008","article-title":"Unmasking barriers in the delivery of preconception counseling and contraception provision for patients with type 1 or type 2 diabetes","volume":"41","author":"Abushamat","year":"2023","journal-title":"Clin Diabetes"},{"issue":"1","key":"2025090312111623200_dgaf288-B41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/whr.2021.0100","article-title":"Facilitators of and barriers to successful implementation of the One Key Question\u00ae pregnancy intention screening tool","volume":"3","author":"Ferketa","year":"2022","journal-title":"Womens Health Rep (New Rochelle)"},{"issue":"8","key":"2025090312111623200_dgaf288-B42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10995-019-02754-z","article-title":"Increase in contraceptive counseling by primary care clinicians after implementation of One Key Question\u00ae at an Urban Community Health Center","volume":"23","author":"Stulberg","year":"2019","journal-title":"Matern Child Health J"},{"key":"2025090312111623200_dgaf288-B43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.contraception.2022.01.004","article-title":"Quantitative and qualitative impact of One Key Question on primary care providers' contraceptive counseling at routine preventive health visits","volume":"109","author":"Thorman","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"2025090312111623200_dgaf288-B44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.contraception.2020.10.018","article-title":"Effects of clinic-level implementation of One Key Question\u00ae on reproductive health counseling and patient satisfaction","volume":"103","author":"Song","year":"2021","journal-title":"Contraception"},{"issue":"23","key":"2025090312111623200_dgaf288-B45","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/bloodadvances.2019000931","article-title":"2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations","volume":"3","author":"Murad","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"2025090312111623200_dgaf288-B46","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0145721716668651","article-title":"Efficacy of the READY-girls program on general risk-taking behaviors, condom use, and sexually transmitted infections among young adolescent females with type 1 diabetes","volume":"42","author":"Thurheimer","year":"2016","journal-title":"Diabetes Educ"},{"issue":"1","key":"2025090312111623200_dgaf288-B47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2337\/dc15-1206","article-title":"Pregnancy outcomes in youth with type 2 diabetes: the TODAY study experience","volume":"39","author":"Klingensmith","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"2025090312111623200_dgaf288-B48","doi-asserted-by":"crossref","first-page":"e14521","DOI":"10.1111\/dme.14521","article-title":"Women with type 1 diabetes and women with type 2 diabetes differ in knowledge and beliefs about contraception and pregnancy","volume":"38","author":"Hendrieckx","year":"2021","journal-title":"Diabet Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40001-023-01626-1","article-title":"Family planning behaviours among women with diabetes mellitus: a scoping review","volume":"29","author":"Awang Dahlan","year":"2024","journal-title":"Eur J Med Res"},{"issue":"3","key":"2025090312111623200_dgaf288-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. Selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"2025090312111623200_dgaf288-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2025090312111623200_dgaf288-B52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.japh.2023.10.037","article-title":"The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception","volume":"64","author":"Skelley","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"2025090312111623200_dgaf288-B53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.fertnstert.2024.02.038","article-title":"Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis","volume":"122","author":"Caldwell","year":"2024","journal-title":"Fertil Steril"},{"issue":"14","key":"2025090312111623200_dgaf288-B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21140","article-title":"Preconception care for women with type 1 or type 2 diabetes mellitus: a mixed-methods study exploring uptake of preconception care","volume":"21","author":"Earle","year":"2017","journal-title":"Health Technol Assess"},{"issue":"4","key":"2025090312111623200_dgaf288-B55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000000184","article-title":"Change in sexual behavior with provision of no-cost contraception","volume":"123","author":"Secura","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"14","key":"2025090312111623200_dgaf288-B56","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1400506","article-title":"Provision of no-cost, long-acting contraception and teenage pregnancy","volume":"371","author":"Secura","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2025090312111623200_dgaf288-B57","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318273eb56","article-title":"Preventing unintended pregnancies by providing no-cost contraception","volume":"120","author":"Peipert","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025090312111623200_dgaf288-B58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/jwh.2015.5191","article-title":"Preventing unintended pregnancy: the contraceptive CHOICE project in review","volume":"24","author":"Birgisson","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"2025090312111623200_dgaf288-B59","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/GRF.0000000000000070","article-title":"The contraceptive CHOICE project round up: what we did and what we learned","volume":"57","author":"McNicholas","year":"2014","journal-title":"Clin Obstet Gynecol"},{"issue":"21","key":"2025090312111623200_dgaf288-B60","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2025090312111623200_dgaf288-B61","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/13625187.2020.1833187","article-title":"Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and meta-analysis","volume":"25","author":"Farah","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"12","key":"2025090312111623200_dgaf288-B62","doi-asserted-by":"crossref","first-page":"e2450635","DOI":"10.1001\/jamanetworkopen.2024.50635","article-title":"Integrating a postpartum contraception intervention in the maternal and child health care system of China: a randomized clinical trial","volume":"7","author":"Yin","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2025090312111623200_dgaf288-B63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2337\/cd17-0028","article-title":"Use of the levonorgestrel intrauterine device in women with type 2 diabetes","volume":"36","author":"Lang","year":"2018","journal-title":"Clin Diabetes"},{"issue":"1","key":"2025090312111623200_dgaf288-B64","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1186\/1471-2458-12-792","article-title":"Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Wahabi","year":"2012","journal-title":"BMC Public Health"},{"issue":"1","key":"2025090312111623200_dgaf288-B65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2393-10-63","article-title":"Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis","volume":"10","author":"Wahabi","year":"2010","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025090312111623200_dgaf288-B66","volume-title":"WHO Guidelines Approved by the Guidelines Review Committee. Medical Eligibility Criteria for Contraceptive Use","author":"Organization WH"},{"key":"2025090312111623200_dgaf288-B67","volume-title":"UK Medical Eligibility Criteria: For Contraceptive Use","author":"FSRH","year":"2019"},{"issue":"2","key":"2025090312111623200_dgaf288-B68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"O'Brien","year":"2017","journal-title":"Diabetes Care"},{"issue":"19","key":"2025090312111623200_dgaf288-B69","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2012-11-469551","article-title":"Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom","volume":"121","author":"Sultan","year":"2013","journal-title":"Blood"},{"key":"2025090312111623200_dgaf288-B70","doi-asserted-by":"publisher","DOI":"10.1055\/a-2489-4539","article-title":"The impact of pregestational diabetes on maternal morbidity and mortality: trends, challenges, and future directions","author":"Murrin","journal-title":"Am J Perinatol"},{"issue":"5","key":"2025090312111623200_dgaf288-B71","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.2337\/dc16-2683","article-title":"Comment on O'Brien et al. Hormonal contraception and risk of thromboembolism in women with diabetes. Diabetes care 2017;40(2):233\u2013238","volume":"40","author":"Braillon","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"2025090312111623200_dgaf288-B72","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","article-title":"Obesity in pregnancy: ACOG practice bulletin, number 230","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025090312111623200_dgaf288-B73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"2 Pt 1","key":"2025090312111623200_dgaf288-B74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AOG.0b013e3181af68b2","article-title":"Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users","volume":"114","author":"Le","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"issue":"6","key":"2025090312111623200_dgaf288-B76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"Horton","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"2025090312111623200_dgaf288-B77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.arthro.2020.10.025","article-title":"Combined oral contraceptive use increases the risk of venous thromboembolism after knee arthroscopy and anterior cruciate ligament reconstruction: an analysis of 64,165 patients in the Truven database","volume":"37","author":"Traven","year":"2021","journal-title":"Arthroscopy"},{"issue":"6","key":"2025090312111623200_dgaf288-B78","doi-asserted-by":"crossref","first-page":"e2218986","DOI":"10.1001\/jamanetworkopen.2022.18986","article-title":"Association of prepregnancy body mass index with risk of severe maternal morbidity and mortality among Medicaid beneficiaries","volume":"5","author":"Frey","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2025090312111623200_dgaf288-B79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcjd.2024.03.001","article-title":"The examination and exploration of diabetes distress in pre-existing diabetes in pregnancy: a mixed-methods study","volume":"48","author":"Tschirhart","year":"2024","journal-title":"Can J Diabetes"},{"issue":"8","key":"2025090312111623200_dgaf288-B80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1037\/hea0000871","article-title":"Daily illness appraisal and collaboration in couples with type 1 diabetes","volume":"39","author":"Berg","year":"2020","journal-title":"Health Psychol"},{"issue":"1","key":"2025090312111623200_dgaf288-B81","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1464-5491.2009.02890.x","article-title":"Personal experiences of women with diabetes who do not attend pre-pregnancy care","volume":"27","author":"Murphy","year":"2010","journal-title":"Diabet Med"},{"issue":"6","key":"2025090312111623200_dgaf288-B82","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/diacare.21.6.889","article-title":"Why don't women with diabetes plan their pregnancies?","volume":"21","author":"Holing","year":"1998","journal-title":"Diabetes Care"},{"issue":"5","key":"2025090312111623200_dgaf288-B83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5539\/gjhs.v8n5p189","article-title":"The women's perceptions about unwanted pregnancy: a qualitative study in Iran","volume":"8","author":"Akbarzadeh","year":"2015","journal-title":"Glob J Health Sci"},{"key":"2025090312111623200_dgaf288-B84","volume-title":"Prevalence and Perceptions of Unplanned Births","author":"Johnston","year":"2017"},{"issue":"1","key":"2025090312111623200_dgaf288-B85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1363\/4502313","article-title":"Young women's perceptions of the benefits of childbearing: associations with contraceptive use and pregnancy","volume":"45","author":"Rocca","year":"2013","journal-title":"Perspect Sex Reprod Health"},{"key":"2025090312111623200_dgaf288-B86","year":"2015"},{"key":"2025090312111623200_dgaf288-B87","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.conx.2020.100036","article-title":"Out-of-pocket spending for oral contraceptives among women with private insurance coverage after the affordable care act","volume":"2","author":"Frederiksen","year":"2020","journal-title":"Contracept X"},{"issue":"7","key":"2025090312111623200_dgaf288-B88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MLR.0000000000000921","article-title":"The relationship between prescription copayments and contraceptive adherence in a new-user cohort","volume":"56","author":"Marshall","year":"2018","journal-title":"Med Care"},{"issue":"5","key":"2025090312111623200_dgaf288-B89","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/AOG.0b013e3182a91f45","article-title":"Twenty-four-month continuation of reversible contraception","volume":"122","author":"O'Neil-Callahan","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40834-022-00206-8","article-title":"Cost-effectiveness of increased contraceptive coverage using family planning benefits cards compared with the standard of care for young women in Uganda","volume":"8","author":"Nuwamanya","year":"2023","journal-title":"Contracept Reprod Med"},{"issue":"3","key":"2025090312111623200_dgaf288-B91","doi-asserted-by":"crossref","first-page":"e2300070","DOI":"10.9745\/GHSP-D-23-00070","article-title":"Inequities in family planning in low- and middle-income countries","volume":"11","author":"Ross","year":"2023","journal-title":"Glob Health Sci Pract"},{"issue":"11","key":"2025090312111623200_dgaf288-B92","doi-asserted-by":"crossref","first-page":"e2024398","DOI":"10.1001\/jamanetworkopen.2020.24398","article-title":"Trends in birth rates after elimination of cost sharing for contraception by the patient protection and affordable care act","volume":"3","author":"Dalton","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2025090312111623200_dgaf288-B93","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/MS9.0000000000001986","article-title":"Empowering access: the U.S.' first over-the-counter birth control pill revolutionizes contraception","volume":"86","author":"Sajid","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"issue":"5","key":"2025090312111623200_dgaf288-B94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jama.2023.10825","article-title":"Over-the-counter oral contraception as an opportunity to reduce contraceptive access inequity","volume":"330","author":"Brandi","year":"2023","journal-title":"JAMA"},{"key":"2025090312111623200_dgaf288-B95","doi-asserted-by":"crossref","first-page":"109950","DOI":"10.1016\/j.contraception.2023.109950","article-title":"Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among black, indigenous, and people of color: an online cross-sectional survey","volume":"120","author":"Key","year":"2023","journal-title":"Contraception"},{"issue":"6","key":"2025090312111623200_dgaf288-B96","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jadohealth.2016.12.024","article-title":"Over-the-counter access to oral contraceptives for adolescents","volume":"60","author":"Upadhya","year":"2017","journal-title":"J Adolesc Health"},{"key":"2025090312111623200_dgaf288-B97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.contraception.2021.10.007","article-title":"Contraceptive values and preferences of pregnant women, postpartum women, women seeking emergency contraceptives, and women seeking abortion services: a systematic review","volume":"111","author":"Dam","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"2025090312111623200_dgaf288-B98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jmwh.12992","article-title":"Women's contraceptive perceptions, beliefs, and attitudes: an integrative review of qualitative research","volume":"65","author":"Alspaugh","year":"2020","journal-title":"J Midwifery Womens Health"},{"key":"2025090312111623200_dgaf288-B99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2021.05.018","article-title":"Contraceptive values and preferences of adolescents and young adults: a systematic review","volume":"111","author":"Ti","year":"2022","journal-title":"Contraception"},{"key":"2025090312111623200_dgaf288-B100","doi-asserted-by":"crossref","first-page":"107739","DOI":"10.1016\/j.pec.2023.107739","article-title":"\u201cA patient should not have to ask\u201d: women's experiences of patient education about preconception care for type 2 diabetes","volume":"112","author":"Britton","year":"2023","journal-title":"Patient Educ Couns"},{"key":"2025090312111623200_dgaf288-B101","doi-asserted-by":"crossref","first-page":"1605564","DOI":"10.3389\/ijph.2023.1605564","article-title":"Strategies for improving postpartum contraception compared with routine maternal care: a systematic review and meta-analysis","volume":"68","author":"Hu","year":"2023","journal-title":"Int J Public Health"},{"issue":"5","key":"2025090312111623200_dgaf288-B102","doi-asserted-by":"crossref","first-page":"e205252","DOI":"10.1001\/jamanetworkopen.2020.5252","article-title":"Association of pharmacist prescription with dispensed duration of hormonal contraception","volume":"3","author":"Rodriguez","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2025090312111623200_dgaf288-B103","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/AOG.0000000000004752","article-title":"Association of pharmacist prescription of contraception with breaks in coverage","volume":"139","author":"Rodriguez","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2025090312111623200_dgaf288-B104","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"Suppl_1","key":"2025090312111623200_dgaf288-B105","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care."},{"issue":"1","key":"2025090312111623200_dgaf288-B106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"Salamun","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025090312111623200_dgaf288-B107","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"Liu","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025090312111623200_dgaf288-B108","volume-title":"Ozempic (Semaglutide)","author":"Nordisk","year":"2025"},{"key":"2025090312111623200_dgaf288-B109","volume-title":"Trulicity (Dulaglutide)","author":"Lilly","year":"2025"},{"key":"2025090312111623200_dgaf288-B110","volume-title":"VICTOZA (Liraglutide)","author":"Nordisk","year":"2025"},{"issue":"10077","key":"2025090312111623200_dgaf288-B111","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"2025090312111623200_dgaf288-B112","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"2025090312111623200_dgaf288-B113","doi-asserted-by":"crossref","first-page":"1214-P","DOI":"10.2337\/db24-1214-P","article-title":"1214-P: prepregnancy use of glucagon-like peptide 1 receptor agonists and gestational weight gain in type 2 diabetes","volume":"73","author":"Maya","year":"2024","journal-title":"Diabetes"},{"issue":"4","key":"2025090312111623200_dgaf288-B114","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1096-9926(199610)54:4<171::AID-TERA1>3.0.CO;2-4","article-title":"Multifactorial basis of the syndrome of diabetic embryopathy","volume":"54","author":"Reece","year":"1996","journal-title":"Teratology"},{"issue":"2","key":"2025090312111623200_dgaf288-B115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2025090312111623200_dgaf288-B116","doi-asserted-by":"crossref","first-page":"1215356","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2025090312111623200_dgaf288-B117","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/CS20220890","article-title":"Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity","volume":"137","author":"Dumolt","year":"2023","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2025090312111623200_dgaf288-B118","doi-asserted-by":"crossref","first-page":"e083550","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six teratology information services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"issue":"6","key":"2025090312111623200_dgaf288-B119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MED.0000000000000835","article-title":"Glucagon-like peptide-1 receptor agonists and safety in the preconception period","volume":"30","author":"Minis","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"2025090312111623200_dgaf288-B120","first-page":"e44644","article-title":"A case report of a pregnant woman with type 2 diabetes mellitus using dulaglutide during the first trimester of pregnancy","volume":"15","author":"Alghamdi","year":"2023","journal-title":"Cureus"},{"issue":"10","key":"2025090312111623200_dgaf288-B121","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/0118715303252109231023115112","article-title":"Case series: exposure to glucagon-like peptide-1 receptor agonist in the first trimester of pregnancy in two siblings","volume":"24","author":"Do\u011fan \u015e","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"2025090312111623200_dgaf288-B122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00592-022-01954-4","article-title":"A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus","volume":"60","author":"Burlina","year":"2023","journal-title":"Acta Diabetol"},{"issue":"10","key":"2025090312111623200_dgaf288-B123","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/dme.12726","article-title":"Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with type 2 diabetes","volume":"32","author":"Greco","year":"2015","journal-title":"Diabet Med"},{"issue":"3\u20134","key":"2025090312111623200_dgaf288-B124","first-page":"70","article-title":"Pregnancy outcome and liraglutide levels in serum and umbilical vein blood of a woman with type 2 diabetes. A case report","volume":"27","author":"Ivani\u0161evi\u0107","year":"2018","journal-title":"Gynaecol perinatol"},{"issue":"2","key":"2025090312111623200_dgaf288-B125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijgo.15092","article-title":"Semaglutide and pregnancy","volume":"163","author":"Skov","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2025090312111623200_dgaf288-B126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/TEN.0b013e3181a5875e","article-title":"Case report: exenatide use during pregnancy","volume":"19","author":"Williams","year":"2009","journal-title":"Endocrinologist"},{"issue":"5","key":"2025090312111623200_dgaf288-B127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1381612825666190321110420","article-title":"Women's beliefs about medicines and adherence to pharmacotherapy in pregnancy: opportunities for community pharmacists","volume":"25","author":"Ceulemans","year":"2019","journal-title":"Curr Pharm Des"},{"key":"2025090312111623200_dgaf288-B128","doi-asserted-by":"crossref","first-page":"106024","DOI":"10.1016\/j.cct.2020.106024","article-title":"Rationale and study design for lifestyle intervention in preparation for pregnancy (LIPP): a randomized controlled trial","volume":"94","author":"Erickson","year":"2020","journal-title":"Contemp Clin Trials"},{"issue":"201","key":"2025090312111623200_dgaf288-B129","first-page":"15","article-title":"Updated methodology to estimate overall and unintended pregnancy rates in the United States. National Center for Health Statistics","volume":"2","author":"Rossen","year":"2023","journal-title":"Vital Health Stat"},{"issue":"6","key":"2025090312111623200_dgaf288-B130","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"ACOG practice bulletin no. 201: pregestational diabetes mellitus","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2013Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B131","doi-asserted-by":"crossref","first-page":"e000759","DOI":"10.1136\/bmjdrc-2019-000759","article-title":"Antidiabetic medication use during pregnancy: an international utilization study","volume":"7","author":"Cesta","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025090312111623200_dgaf288-B132","doi-asserted-by":"crossref","first-page":"9804708","DOI":"10.1155\/2019\/9804708","article-title":"Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis","volume":"2019","author":"Guo","year":"2019","journal-title":"J Diabetes Res"},{"issue":"8","key":"2025090312111623200_dgaf288-B133","first-page":"Cd012327","article-title":"Treatments for women with gestational diabetes mellitus: an overview of cochrane systematic reviews","volume":"8","author":"Martis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025090312111623200_dgaf288-B134","doi-asserted-by":"crossref","first-page":"367.e1","DOI":"10.1016\/j.ajog.2018.06.013","article-title":"A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes","volume":"219","author":"Barbour","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2025090312111623200_dgaf288-B135","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2337\/dci21-0027","article-title":"Epidemiology and therapeutic strategies for women with preexisting diabetes in pregnancy: how far have we come? The 2021 Norbert Freinkel award lecture","volume":"45","author":"Feig","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B136","doi-asserted-by":"crossref","first-page":"e088653","DOI":"10.1136\/bmjopen-2024-088653","article-title":"Intrauterine metformin exposure and adiposity outcomes in children: a systematic review and meta-analysis","volume":"15","author":"Fu","year":"2025","journal-title":"BMJ Open"},{"issue":"3","key":"2025090312111623200_dgaf288-B137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","article-title":"Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial","volume":"3","author":"Hanem","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"2025090312111623200_dgaf288-B138","doi-asserted-by":"crossref","first-page":"110780","DOI":"10.1016\/j.diabres.2023.110780","article-title":"Metformin versus insulin for gestational diabetes: adiposity variables and adipocytokines in offspring at age of 9 years","volume":"202","author":"Paavilainen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2025090312111623200_dgaf288-B139","doi-asserted-by":"crossref","first-page":"e000456","DOI":"10.1136\/bmjdrc-2017-000456","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age","volume":"6","author":"Rowan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"2025090312111623200_dgaf288-B140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/dci18-0055","article-title":"Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach","volume":"42","author":"Barbour","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"2025090312111623200_dgaf288-B141","doi-asserted-by":"crossref","first-page":"352.e1","DOI":"10.1016\/j.ajog.2024.06.002","article-title":"Initiation of metformin in early pregnancy results in fetal bioaccumulation, growth restriction, and renal dysmorphology in a primate model","volume":"231","author":"Bolte","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2025090312111623200_dgaf288-B142","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12020-023-03550-0","article-title":"Efficacy and safety of metformin during pregnancy: an update","volume":"83","author":"Paschou","year":"2024","journal-title":"Endocrine"},{"key":"2025090312111623200_dgaf288-B143","doi-asserted-by":"crossref","first-page":"k2477","DOI":"10.1136\/bmj.k2477","article-title":"Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study","volume":"361","author":"Given","year":"2018","journal-title":"BMJ"},{"issue":"22","key":"2025090312111623200_dgaf288-B144","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/jama.2023.22949","article-title":"Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy: the MOMPOD randomized clinical trial","volume":"330","author":"Boggess","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"2025090312111623200_dgaf288-B145","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025090312111623200_dgaf288-B146","doi-asserted-by":"crossref","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PLoS Med"},{"key":"2025090312111623200_dgaf288-B147","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2337\/dc23-2056","article-title":"Perinatal outcomes associated with metformin use during pregnancy in women with pregestational type 2 diabetes mellitus","volume":"47","author":"Yland","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"2025090312111623200_dgaf288-B148","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(23)00004-9","article-title":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy kids): a 24-month follow-up of the MiTy randomised controlled trial","volume":"11","author":"Feig","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2025090312111623200_dgaf288-B149","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eprac.2024.05.017","article-title":"Long-term impact on offspring (5 to 11 years of age) of metformin use in pregnancy in mothers with diabetes: a systematic review and meta-analysis","volume":"30","author":"Dutta","year":"2024","journal-title":"Endocr Pract"},{"issue":"12","key":"2025090312111623200_dgaf288-B150","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s00125-022-05789-0","article-title":"Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring","volume":"65","author":"Schoonejans","year":"2022","journal-title":"Diabetologia"},{"issue":"9","key":"2025090312111623200_dgaf288-B151","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00125-017-4351-y","article-title":"Metformin use in pregnancy: promises and uncertainties","volume":"60","author":"Lindsay","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"2025090312111623200_dgaf288-B152","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2337\/dc22-0013","article-title":"Determinants of small for gestational age in women with type 2 diabetes in pregnancy: who should receive metformin?","volume":"45","author":"Feig","year":"2022","journal-title":"Diabetes Care"},{"key":"2025090312111623200_dgaf288-B153","doi-asserted-by":"crossref","first-page":"325851","DOI":"10.1155\/2015\/325851","article-title":"Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy","volume":"2015","author":"Ainuddin","year":"2015","journal-title":"J Diabetes Res"},{"issue":"22","key":"2025090312111623200_dgaf288-B154","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.3390\/nu14224867","article-title":"Dietary advice to support glycaemic control and weight management in women with type 1 diabetes during pregnancy and breastfeeding","volume":"14","author":"Ringholm","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"2025090312111623200_dgaf288-B155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/jhn.13042","article-title":"Carbohydrate quantity is more closely associated with glycaemic control than weight in pregnant women with type 1 diabetes: insights from the diabetes and pre-eclampsia intervention trial (DAPIT)","volume":"35","author":"Hill","year":"2022","journal-title":"J Hum Nutr Diet"},{"issue":"9","key":"2025090312111623200_dgaf288-B156","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1111\/dom.15124","article-title":"Efficacy and safety of carbohydrate restriction in patients with type 1 diabetes: a systematic review and meta-analysis","volume":"25","author":"Stamati","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"2025090312111623200_dgaf288-B157","doi-asserted-by":"crossref","first-page":"e0194987","DOI":"10.1371\/journal.pone.0194987","article-title":"Low-carbohydrate diets for type 1 diabetes mellitus: a systematic review","volume":"13","author":"Turton","year":"2018","journal-title":"PLoS One"},{"issue":"20","key":"2025090312111623200_dgaf288-B158","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/nu14204391","article-title":"Comparison of the effectiveness of low carbohydrate versus low fat diets, in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Apekey","year":"2022","journal-title":"Nutrients"},{"issue":"10","key":"2025090312111623200_dgaf288-B159","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jdi.14271","article-title":"Efficacy of long-term low carbohydrate diets for patients with type 2 diabetes: a systematic review and meta-analysis","volume":"15","author":"Ichikawa","year":"2024","journal-title":"J Diabetes Investig"},{"issue":"Suppl_1","key":"2025090312111623200_dgaf288-B160","doi-asserted-by":"publisher","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"Management of diabetes in pregnancy: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"2","key":"2025090312111623200_dgaf288-B161","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajcnut.2022.09.005","article-title":"Re-examination of the estimated average requirement for carbohydrate intake during pregnancy: addition of placental glucose consumption","volume":"117","author":"Hernandez","year":"2023","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2025090312111623200_dgaf288-B162","doi-asserted-by":"crossref","first-page":"100245","DOI":"10.1016\/j.xagr.2023.100245","article-title":"The role of technology in the care of diabetes mellitus in pregnancy: an expert review","volume":"3","author":"Thayer","year":"2023","journal-title":"AJOG Glob Rep"},{"issue":"2","key":"2025090312111623200_dgaf288-B163","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI118803","article-title":"Contributions of gluconeogenesis to glucose production in the fasted state","volume":"98","author":"Landau","year":"1996","journal-title":"J Clin Invest"},{"issue":"5031","key":"2025090312111623200_dgaf288-B164","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.1948033","article-title":"Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR","volume":"254","author":"Rothman","year":"1991","journal-title":"Science"},{"issue":"3961","key":"2025090312111623200_dgaf288-B165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.170.3961.990","article-title":"Starvation in human pregnancy: hypoglycemia, hypoinsulinemia, and hyperketonemia","volume":"170","author":"Felig","year":"1970","journal-title":"Science"},{"issue":"1","key":"2025090312111623200_dgaf288-B166","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/diacare.24.1.131","article-title":"Management of hyperglycemic crises in patients with diabetes","volume":"24","author":"Kitabchi","year":"2001","journal-title":"Diabetes Care"},{"issue":"7","key":"2025090312111623200_dgaf288-B167","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41574-019-0197-3","article-title":"Improving pregnancy outcomes in women with diabetes mellitus: modern management","volume":"15","author":"Ringholm","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"9514","key":"2025090312111623200_dgaf288-B168","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(06)68394-3","article-title":"A life-threatening complication of atkins diet","volume":"367","author":"Chen","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"2025090312111623200_dgaf288-B169","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00125-023-06044-w","article-title":"Habitual carbohydrate intake is not correlated with circulating beta-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation","volume":"67","author":"Tanner","year":"2024","journal-title":"Diabetologia"},{"issue":"1","key":"2025090312111623200_dgaf288-B170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12889-024-17862-x","article-title":"Maternal macronutrient and energy intake during pregnancy: a systematic review and meta-analysis","volume":"24","author":"Khammarnia","year":"2024","journal-title":"BMC Public Health"},{"issue":"13","key":"2025090312111623200_dgaf288-B171","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJM199109263251303","article-title":"Correlations between antepartum maternal metabolism and intelligence of offspring","volume":"325","author":"Rizzo","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"2025090312111623200_dgaf288-B172","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bdr2.1466","article-title":"Women's periconceptional lowered carbohydrate intake and NTD-affected pregnancy risk in the era of prefortification with folic acid","volume":"111","author":"Shaw","year":"2019","journal-title":"Birth Defects Res"},{"issue":"3","key":"2025090312111623200_dgaf288-B173","doi-asserted-by":"crossref","first-page":"e2328","DOI":"10.1002\/bdr2.2328","article-title":"A search for factors associated with reduced carbohydrate intake and NTD risk in two population-based studies","volume":"116","author":"Shaw","year":"2024","journal-title":"Birth Defects Res"},{"issue":"11","key":"2025090312111623200_dgaf288-B174","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/bdr2.1198","article-title":"Low carbohydrate diets may increase risk of neural tube defects","volume":"110","author":"Desrosiers","year":"2018","journal-title":"Birth Defects Res"},{"issue":"10","key":"2025090312111623200_dgaf288-B175","doi-asserted-by":"crossref","first-page":"e0292810","DOI":"10.1371\/journal.pone.0292810","article-title":"Changes in the prevalence of U.S. Adults using diet, exercise, pharmaceuticals and diet products for weight loss over time: analysis of NHANES 1999\u20132018","volume":"18","author":"Kuk","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"2025090312111623200_dgaf288-B176","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcjd.2013.07.043","article-title":"Costs of recalled and recommended diets for pregnant women with type 1, type 2 and gestational diabetes","volume":"37","author":"McManus","year":"2013","journal-title":"Can J Diabetes"},{"issue":"11","key":"2025090312111623200_dgaf288-B177","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/dme.13937","article-title":"Dietary intakes of women with type 1 diabetes before and during pregnancy: a pre-specified secondary subgroup analysis among CONCEPTT participants","volume":"37","author":"Neoh","year":"2020","journal-title":"Diabet Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B178","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2337\/dc19-1908","article-title":"Dietary patterns of insulin pump and multiple daily injection users during type 1 diabetes pregnancy","volume":"43","author":"Neoh","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B179","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/fsn3.1982","article-title":"Dietary intake of carbohydrates in pregnant women with type 1 diabetes-A narrative review","volume":"9","author":"Roskj\u00e6r","year":"2021","journal-title":"Food Sci Nutr"},{"key":"2025090312111623200_dgaf288-B180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.diabres.2019.05.012","article-title":"Lower daily carbohydrate consumption than recommended by the institute of medicine is common among women with type 2 diabetes in early pregnancy in Denmark","volume":"152","author":"\u00c1sbj\u00f6rnsd\u00f3ttir","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2025090312111623200_dgaf288-B181","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/dom.15442","article-title":"REduced-Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes (RECORD): a randomized controlled feasibility trial","volume":"26","author":"Michalopoulou","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025090312111623200_dgaf288-B182","author":"Mijatovic J, Louie JCY, Buso MEC","year":"2020","journal-title":"Am J Clin Nutr."},{"key":"2025090312111623200_dgaf288-B183","author":"Moreno-Castilla C, Hernandez M, Bergua M","year":"2013","journal-title":"Diabetes Care"},{"key":"2025090312111623200_dgaf288-B184","author":"Han S, Middleton P, Shepherd E, Van Ryswyk E, Crowther CA.","year":"2017"},{"key":"2025090312111623200_dgaf288-B185","author":"Wong MMH, Yuen-Man Chan M, Ng TP, Louie JCY.","year":"2024"},{"key":"2025090312111623200_dgaf288-B186","author":"Sweeting A, Mijatovic J, Brinkworth GD","year":"2021"},{"issue":"8","key":"2025090312111623200_dgaf288-B187","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/dc11-0244","article-title":"Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial","volume":"34","author":"Holmes","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"2025090312111623200_dgaf288-B188","doi-asserted-by":"crossref","first-page":"e12916","DOI":"10.1111\/mcn.12916","article-title":"Dietary guideline adherence during preconception and pregnancy: a systematic review","volume":"16","author":"Caut","year":"2020","journal-title":"Matern Child Nutr"},{"issue":"8","key":"2025090312111623200_dgaf288-B189","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/09637486.2024.2415126","article-title":"Modelling the cost differential between current and healthy diets according to household education level in Belgium","volume":"75","author":"Pedroni","year":"2024","journal-title":"Int J Food Sci Nutr"},{"issue":"2","key":"2025090312111623200_dgaf288-B190","doi-asserted-by":"crossref","first-page":"177.e1","DOI":"10.1016\/j.ajog.2016.10.007","article-title":"Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in northern California: 1996\u20132014","volume":"216","author":"Peng","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2025090312111623200_dgaf288-B191","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2009-1231","article-title":"Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis","volume":"94","author":"Balsells","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025090312111623200_dgaf288-B192","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/diacare.28.2.323","article-title":"Poor pregnancy outcome in women with type 2 diabetes","volume":"28","author":"Clausen","year":"2005","journal-title":"Diabetes Care"},{"issue":"10","key":"2025090312111623200_dgaf288-B193","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2337\/dc07-0555","article-title":"Differing causes of pregnancy loss in type 1 and type 2 diabetes","volume":"30","author":"Cundy","year":"2007","journal-title":"Diabetes Care"},{"issue":"12","key":"2025090312111623200_dgaf288-B194","first-page":"e240066","article-title":"Pregnancy outcomes in type 2 versus type 1 diabetes: systematic review with meta-analyses","volume":"13","author":"Drabl\u00f8s","year":"2024","journal-title":"Endocr Connect"},{"issue":"3","key":"2025090312111623200_dgaf288-B195","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ecl.2019.05.009","article-title":"Type 2 diabetes in pregnancy","volume":"48","author":"Kapur","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"2025090312111623200_dgaf288-B196","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-019-4943-9","article-title":"Factors associated with stillbirth in women with diabetes","volume":"62","author":"Mackin","year":"2019","journal-title":"Diabetologia"},{"issue":"2","key":"2025090312111623200_dgaf288-B197","doi-asserted-by":"crossref","first-page":"e010222200742","DOI":"10.2174\/1573399818666220201111200","article-title":"Treating to target glycaemia in type 2 diabetes pregnancy","volume":"19","author":"Yamamoto","year":"2023","journal-title":"Curr Diabetes Rev"},{"issue":"Suppl 1","key":"2025090312111623200_dgaf288-B198","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc24-SINT","article-title":"Introduction and methodology: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025090312111623200_dgaf288-B199","first-page":"2012","article-title":"The effect of real-time continuous glucose monitoring in diabetic pregnancy\u2014a randomised controlled trial","volume":"55","author":"Secher","year":"2012","journal-title":"Diabetologia"},{"issue":"8","key":"2025090312111623200_dgaf288-B200","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/dom.13310","article-title":"Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2025090312111623200_dgaf288-B201","doi-asserted-by":"crossref","first-page":"a1680","DOI":"10.1136\/bmj.a1680","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial","volume":"337","author":"Murphy","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"2025090312111623200_dgaf288-B202","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"2025090312111623200_dgaf288-B203","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1111\/dom.15276","article-title":"Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: a post-hoc analysis of the GlucoMOMS trial","volume":"25","author":"Rademaker","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2025090312111623200_dgaf288-B204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/ds20-0103","article-title":"Time in range in pregnancy: is there a role?","volume":"34","author":"Wyckoff","year":"2021","journal-title":"Diabetes Spectr"},{"issue":"5","key":"2025090312111623200_dgaf288-B205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/AOG.0000000000005609","article-title":"Continuous glucose monitoring for management of type 2 diabetes and perinatal outcomes","volume":"144","author":"Padgett","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc23-0636","article-title":"Association of continuous glucose monitoring metrics with pregnancy outcomes in patients with preexisting diabetes","volume":"47","author":"Sanusi","year":"2024","journal-title":"Diabetes Care"},{"key":"2025090312111623200_dgaf288-B207","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0599","article-title":"Continuous glucose monitoring in type 1 diabetes, type 2 diabetes, and diabetes during pregnancy: a systematic review with meta-analysis of randomized controlled trials","author":"Rizos","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"2025090312111623200_dgaf288-B208","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"issue":"4","key":"2025090312111623200_dgaf288-B209","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc22-2189","article-title":"Initiation of continuous glucose monitoring is linked to improved glycemic control and fewer clinical events in type 1 and type 2 diabetes in the Veterans Health Administration","volume":"46","author":"Reaven","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B210","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2024.03.026","article-title":"Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes","volume":"231","author":"Battarbee","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2025090312111623200_dgaf288-B211","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/dia.2023.0300","article-title":"Continuous glucose monitoring metrics in high-risk pregnant women with type 2 diabetes","volume":"25","author":"McLean","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2025090312111623200_dgaf288-B212","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/19322968221124956","article-title":"Feasibility and acceptability of intermittently scanned continuous glucose monitoring for women with type 2 diabetes in pregnancy","volume":"17","author":"McLean","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"2025090312111623200_dgaf288-B213","doi-asserted-by":"crossref","first-page":"100969","DOI":"10.1016\/j.ajogmf.2023.100969","article-title":"Continuous glucose monitor use in type 2 diabetes mellitus in pregnancy and perinatal outcomes: a systematic review and meta-analysis","volume":"5","author":"Wilkie","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"2025090312111623200_dgaf288-B214","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00125-024-06216-2","article-title":"Technology advances in diabetes pregnancy: right technology, right person, right time","volume":"67","author":"McLean","year":"2024","journal-title":"Diabetologia"},{"issue":"5","key":"2025090312111623200_dgaf288-B215","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/AOG.0000000000005668","article-title":"Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes","volume":"144","author":"Durnwald","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2025090312111623200_dgaf288-B216","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/19322968241239341","article-title":"Continuous glucose monitoring metrics for pregnancies complicated by diabetes: critical appraisal of current evidence","volume":"18","author":"Szmuilowicz","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"2025090312111623200_dgaf288-B217","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"2025090312111623200_dgaf288-B218","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11892-018-1008-2","article-title":"Maternal non-glycemic contributors to fetal growth in obesity and gestational diabetes: spotlight on lipids","volume":"18","author":"Barbour","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2025090312111623200_dgaf288-B219","volume-title":"Continuous Glucose Monitoring Amongst Pregnant Women With Early-Onset Type 2 Diabetes","author":"Murphy","year":"2023"},{"key":"2025090312111623200_dgaf288-B220","volume-title":"Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching","author":"Venkatesh","year":"2025"},{"issue":"6","key":"2025090312111623200_dgaf288-B221","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1932296820972123","article-title":"Changes in device uptake and glycemic control among pregnant women with type 1 diabetes: data from the T1D exchange","volume":"15","author":"Levy","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"2025090312111623200_dgaf288-B222","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.2337\/dci19-0013","article-title":"Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes care. 2018;41(12):2471-2479","volume":"42","author":"Feig","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"2025090312111623200_dgaf288-B223","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"issue":"7","key":"2025090312111623200_dgaf288-B224","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00125-019-4904-3","article-title":"Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters","volume":"62","author":"Murphy","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"2025090312111623200_dgaf288-B225","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ajo.12521","article-title":"Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes","volume":"57","author":"Abell","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"10","key":"2025090312111623200_dgaf288-B226","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/diacare.15.10.1251","article-title":"Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy","volume":"15","author":"Combs","year":"1992","journal-title":"Diabetes Care"},{"issue":"2","key":"2025090312111623200_dgaf288-B227","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12020-016-1134-z","article-title":"Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control","volume":"55","author":"Cyganek","year":"2017","journal-title":"Endocrine"},{"issue":"19","key":"2025090312111623200_dgaf288-B228","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199511093331901","article-title":"Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy","volume":"333","author":"de Veciana","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"2025090312111623200_dgaf288-B229","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/dme.13585","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: benefits for mothers, using pumps or pens, and their babies","volume":"35","author":"Feig","year":"2018","journal-title":"Diabet Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2337\/dci23-0079","article-title":"Optimizing patient outcomes in pregnancy: what continuous glucose monitoring metrics should we be aiming for?","volume":"47","author":"Feig","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B231","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0002-9378(91)90637-7","article-title":"Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. The National Institute of Child Health and Human Development\u2014diabetes in early pregnancy study","volume":"164","author":"Jovanovic-Peterson","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2025090312111623200_dgaf288-B232","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/0002-9378(88)90578-9","article-title":"The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes","volume":"159","author":"Langer","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2025090312111623200_dgaf288-B233","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/dc18-2212","article-title":"Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus","volume":"42","author":"Law","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"2025090312111623200_dgaf288-B234","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1067\/S0002-9378(03)00497-6","article-title":"Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial","volume":"189","author":"Manderson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2025090312111623200_dgaf288-B235","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.3390\/jcm12113852","article-title":"Association between HbA1c levels and fetal macrosomia and large for gestational age babies in women with gestational diabetes mellitus: a systematic review and meta-analysis of 17,711 women","volume":"12","author":"Mou","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"2025090312111623200_dgaf288-B236","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2337\/dc06-0914","article-title":"Hba1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes","volume":"29","author":"Nielsen","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B237","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12884-023-06241-w","article-title":"Early to mid-pregnancy HbA1c levels and its association with adverse pregnancy outcomes in three low middle-income countries in Asia and sub-saharan Africa","volume":"24","author":"Nisar","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2025090312111623200_dgaf288-B238","first-page":"133","article-title":"Maternal postprandial blood glucose levels influence infant birth weight in diabetic pregnancy","volume":"19","author":"Parfitt","year":"1992","journal-title":"Diabetes Res"},{"issue":"8","key":"2025090312111623200_dgaf288-B239","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1089\/dia.2023.0583","article-title":"Mean glucose and gestational weight gain as predictors of large-for-gestational-age infants in pregnant women with type 1 diabetes using continuous glucose monitoring","volume":"26","author":"S\u00f8holm","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2025090312111623200_dgaf288-B240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s001250050010","article-title":"Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus","volume":"43","author":"Suhonen","year":"2000","journal-title":"Diabetologia"},{"issue":"1","key":"2025090312111623200_dgaf288-B241","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ejendo\/lvac019","article-title":"Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China","volume":"188","author":"Yang","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025090312111623200_dgaf288-B242","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00592-020-01655-w","article-title":"1-Hour postprandial glucose target of&lt;120 mg\/dL is superior to&lt;140 mg\/dL in the treatment for gestational diabetes mellitus in relation to pregnancy outcomes: a retrospective study","volume":"58","author":"\u017burawska-Kli\u015b","year":"2021","journal-title":"Acta Diabetol"},{"issue":"8","key":"2025090312111623200_dgaf288-B243","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc22-0078","article-title":"Continuous glucose monitoring metrics and birth weight: informing management of type 1 diabetes throughout pregnancy","volume":"45","author":"Scott","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"2025090312111623200_dgaf288-B244","first-page":"16501","article-title":"Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study","volume":"133","author":"Sibiak","year":"2023","journal-title":"Pol Arch Intern Med"},{"issue":"8","key":"2025090312111623200_dgaf288-B245","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/dme.13988","article-title":"Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial","volume":"36","author":"Yamamoto","year":"2019","journal-title":"Diabet Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B246","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12884-016-0961-5","article-title":"CONCEPTT: continuous glucose monitoring in women with type 1 diabetes in pregnancy trial: a multi-center, multi-national, randomized controlled trial\u2014study protocol","volume":"16","author":"Feig","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2025090312111623200_dgaf288-B247","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2337\/dc20-2360","article-title":"Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes","volume":"44","author":"Meek","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"2025090312111623200_dgaf288-B248","first-page":"CD008540","article-title":"Different intensities of glycaemic control for pregnant women with pre-existing diabetes","volume":"2016","author":"Middleton","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"2025090312111623200_dgaf288-B249","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1210\/clinem\/dgae291","article-title":"Basal hyperglycemia contributes more than 50% to time in range in pregnant women with type 1 diabetes","volume":"109","author":"Ling","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2025090312111623200_dgaf288-B250","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated insulin delivery in women with pregnancy complicated by type 1 diabetes","volume":"389","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"2025090312111623200_dgaf288-B251","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.diabres.2022.109825","article-title":"Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: a systematic literature review","volume":"186","author":"Aggarwal","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2025090312111623200_dgaf288-B252","doi-asserted-by":"crossref","first-page":"e002580","DOI":"10.1136\/bmjdrc-2021-002580","article-title":"FreeStyle libre flash glucose monitoring system for people with type 1 diabetes in the UK: a budget impact analysis","volume":"10","author":"Blissett","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"2025090312111623200_dgaf288-B253","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/1932296818777265","article-title":"Health care costs, hospital admissions, and glycemic control using a standalone, real-time, continuous glucose monitoring system in commercially insured patients with type 1 diabetes","volume":"12","author":"Gill","year":"2018","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 1","key":"2025090312111623200_dgaf288-B254","first-page":"2019","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: cost-effectiveness analyses of the conceptt randomized controlled trial","volume":"68","author":"Murphy","year":"2019","journal-title":"Diabetes"},{"key":"2025090312111623200_dgaf288-B255","first-page":"14","article-title":"Continuous glucose monitoring: a cost-effective tool to reduce pre-term birth rates in women with type one diabetes","volume":"14","author":"Sekhon","year":"2022","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"2025090312111623200_dgaf288-B256","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1055\/a-1904-9279","article-title":"Time in range and pregnancy outcomes in people with diabetes using continuous glucose monitoring","volume":"40","author":"Fishel Bartal","year":"2023","journal-title":"Am J Perinatol"},{"issue":"10","key":"2025090312111623200_dgaf288-B257","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/dia.2021.0073","article-title":"Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes","volume":"23","author":"Tundidor","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"2025090312111623200_dgaf288-B258","doi-asserted-by":"crossref","first-page":"e4309","DOI":"10.1210\/clinem\/dgab502","article-title":"Achieving the HbA1c target requires longer time in range in pregnant women with type 1 diabetes","volume":"106","author":"Ling","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025090312111623200_dgaf288-B259","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9378(89)90371-2","article-title":"Glycemic control in gestational diabetes mellitus--how tight is tight enough: small for gestational age versus large for gestational age?","volume":"161","author":"Langer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2025090312111623200_dgaf288-B260","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.28.5.1113","article-title":"Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes","volume":"28","author":"Jovanovic","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"2025090312111623200_dgaf288-B261","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","article-title":"Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial","volume":"12","author":"Benhalima","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025090312111623200_dgaf288-B262","first-page":"596","article-title":"Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes","volume":"26","author":"Quir\u00f3s","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2025090312111623200_dgaf288-B263","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"2025090312111623200_dgaf288-B264","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"2025090312111623200_dgaf288-B265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/dia.2024.0012","article-title":"Randomized trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy","volume":"26","author":"Polsky","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2025090312111623200_dgaf288-B266","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dia.2018.0060","article-title":"Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","volume":"20","author":"Stewart","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2025090312111623200_dgaf288-B267","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/dia.2022.0479","article-title":"Rollout of closed-loop technology to pregnant women with type 1 diabetes: healthcare professionals' views about potential challenges and solutions","volume":"25","author":"Rankin","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2025090312111623200_dgaf288-B268","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/dia.2021.0521","article-title":"Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm","volume":"24","author":"Ozaslan","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2025090312111623200_dgaf288-B269","doi-asserted-by":"crossref","first-page":"e15086","DOI":"10.1111\/dme.15086","article-title":"Real-world use of control-IQ \u2122 technology automated insulin delivery in pregnancy: a case series with qualitative interviews","volume":"40","author":"Wang","year":"2023","journal-title":"Diabet Med"},{"issue":"12","key":"2025090312111623200_dgaf288-B270","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/dia.2023.0323","article-title":"Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy","volume":"25","author":"Lawton","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2025090312111623200_dgaf288-B271","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00592-025-02446-x","article-title":"Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"62","author":"Stamati","year":"2025","journal-title":"Acta Diabetol"},{"issue":"9","key":"2025090312111623200_dgaf288-B272","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1111\/dom.15718","article-title":"Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: a meta-analysis","volume":"26","author":"Yang","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2025090312111623200_dgaf288-B273","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajog.2024.11.026","article-title":"Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis","volume":"232","author":"Clement","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B274","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/AOG.0000000000004447","volume":"138","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2021","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"2025090312111623200_dgaf288-B275","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9378(93)90631-R","article-title":"Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management","volume":"169","author":"Kjos","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2025090312111623200_dgaf288-B276","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/AOG.0000000000005682","article-title":"Pre-existing diabetes and stillbirth or perinatal mortality: a systematic review and meta-analysis","volume":"144","author":"Blankstein","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025090312111623200_dgaf288-B277","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/14767058.2019.1607287","article-title":"The joint effects of obesity and pregestational diabetes on the risk of stillbirth","volume":"34","author":"Browne","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2025090312111623200_dgaf288-B278","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1800566","article-title":"Labor induction versus expectant management in low-risk nulliparous women","volume":"379","author":"Grobman","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"2025090312111623200_dgaf288-B279","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa0803267","article-title":"Timing of elective repeat cesarean delivery at term and neonatal outcomes","volume":"360","author":"Tita","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2025090312111623200_dgaf288-B280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/aogs.13761","article-title":"Timing of delivery in women with diabetes: a population-based study","volume":"99","author":"Metcalfe","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2025090312111623200_dgaf288-B281","doi-asserted-by":"crossref","first-page":"e000758","DOI":"10.1136\/bmjdrc-2019-000758","article-title":"Timing of delivery in women with pre-pregnancy diabetes mellitus: a population-based study","volume":"7","author":"Brown","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B282","first-page":"S141","article-title":"238 optimal timing of delivery in pregnancies complicated by pregestational diabetes: a population-based study","volume":"230","author":"Makhamreh","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025090312111623200_dgaf288-B283","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/AOG.0000000000003930","article-title":"Cost of elective labor induction compared with expectant management in nulliparous women","volume":"136","author":"Einerson","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025090312111623200_dgaf288-B284","doi-asserted-by":"crossref","first-page":"590.e1","DOI":"10.1016\/j.ajog.2019.02.017","article-title":"Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis","volume":"220","author":"Hersh","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2025090312111623200_dgaf288-B285","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/AOG.0000000000003014","volume-title":"Obstet Gynecol","author":"ACOG committee opinion no. 762: prepregnancy counseling","year":"2019"},{"key":"2025090312111623200_dgaf288-B286","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1210\/clinem\/dgaa931","article-title":"Type 1 diabetes: management in women from preconception to postpartum","volume-title":"J Clin Endocrinol Metab","author":"Buschur","year":"2021"},{"issue":"3","key":"2025090312111623200_dgaf288-B287","doi-asserted-by":"crossref","first-page":"102425","DOI":"10.1016\/j.dsx.2022.102425","article-title":"Executive summary of evidence and consensus-based clinical practice guideline for management of obesity and overweight in postpartum women: an AIIMS-DST initiative","volume":"16","author":"Kumari","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"2025090312111623200_dgaf288-B288","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nwh.2019.09.004","article-title":"Consolidation of guidelines of postpartum care recommendations to address maternal morbidity and mortality","volume":"23","author":"Walker","year":"2019","journal-title":"Nurs Womens Health"},{"issue":"1","key":"2025090312111623200_dgaf288-B289","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12884-019-2293-8","article-title":"Gestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesity","volume":"19","author":"Brown","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025090312111623200_dgaf288-B290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bpobgyn.2019.03.008","article-title":"Postpartum care of women with renal disease","volume":"57","author":"Pillay","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"2025090312111623200_dgaf288-B291","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.whi.2021.06.003","article-title":"Postpartum transition of care: racial\/ethnic gaps in veterans' re-engagement in VA primary care after pregnancy","volume":"31","author":"Shankar","year":"2021","journal-title":"Womens Health Issues"},{"issue":"Suppl 1","key":"2025090312111623200_dgaf288-B292","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10995-016-2184-9","article-title":"Predictors of non-attendance to the postpartum follow-up visit","volume":"20","author":"Wilcox","year":"2016","journal-title":"Matern Child Health J"},{"issue":"4","key":"2025090312111623200_dgaf288-B293","doi-asserted-by":"crossref","first-page":"100363","DOI":"10.1016\/j.ajogmf.2021.100363","article-title":"Randomized control trial of postpartum visits at 2 and 6 weeks","volume":"3","author":"Pluym","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"18","key":"2025090312111623200_dgaf288-B294","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","article-title":"Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period","volume":"132","author":"Goel","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"2025090312111623200_dgaf288-B295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/AOG.0000000000005437","article-title":"Risk factors, trends, and outcomes associated with postpartum sepsis readmissions","volume":"143","author":"Liu","year":"2024","journal-title":"Obstet Gynecol"},{"key":"2025090312111623200_dgaf288-B296","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejogrb.2019.07.020","article-title":"Incisional surgical site infection following cesarean section: a national retrospective cohort study","volume":"240","author":"Saeed","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2025090312111623200_dgaf288-B297","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4158\/EP.15.3.187","article-title":"Breastfeeding and the basal insulin requirement in type 1 diabetic women","volume":"15","author":"Riviello","year":"2009","journal-title":"Endocr Pract"},{"issue":"1","key":"2025090312111623200_dgaf288-B298","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6874-11-10","article-title":"Extraordinary exposed in early motherhood\u2014a qualitative study exploring experiences of mothers with type 1 diabetes","volume":"11","author":"Sparud-Lundin","year":"2011","journal-title":"BMC Womens Health"},{"issue":"9","key":"2025090312111623200_dgaf288-B299","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/dme.12238","article-title":"Breastfeeding in women with diabetes: lower rates despite greater rewards. A population-based study","volume":"30","author":"Finkelstein","year":"2013","journal-title":"Diabet Med"},{"issue":"1","key":"2025090312111623200_dgaf288-B300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.07.006","article-title":"Breastfeeding practices that support women with diabetes to breastfeed","volume":"110","author":"Fallon","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2025090312111623200_dgaf288-B301","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11892-004-0040-6","article-title":"Lactation, diabetes, and nutrition recommendations","volume":"4","author":"Reader","year":"2004","journal-title":"Curr Diab Rep"},{"issue":"5","key":"2025090312111623200_dgaf288-B302","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/07315724.2005.10719480","article-title":"A systematic review of the literature associating breastfeeding with type 2 diabetes and gestational diabetes","volume":"24","author":"Taylor","year":"2005","journal-title":"J Am Coll Nutr"},{"issue":"Suppl 2","key":"2025090312111623200_dgaf288-B303","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.2337\/dc07-s220","article-title":"Treatment with insulin and its analogs in pregnancies complicated by diabetes","volume":"30","author":"Jovanovic","year":"2007","journal-title":"Diabetes Care"},{"issue":"7","key":"2025090312111623200_dgaf288-B304","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/dme.12993","article-title":"Glycaemic behaviour during breastfeeding in women with type 1 diabetes","volume":"33","author":"Achong","year":"2016","journal-title":"Diabet Med"},{"issue":"4","key":"2025090312111623200_dgaf288-B305","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1210\/jc.2015-3817","article-title":"Ten years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy-the Atlantic DIP experience","volume":"101","author":"Owens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025090312111623200_dgaf288-B306","doi-asserted-by":"crossref","first-page":"160.e1","DOI":"10.1016\/j.ajog.2023.01.002","article-title":"Postpartum navigation decreases severe maternal morbidity most among Black women","volume":"229","author":"Brown","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2025090312111623200_dgaf288-B307","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc23-0882","article-title":"A randomized trial of closed-loop insulin delivery postpartum in type 1 diabetes","volume":"46","author":"Donovan","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"2025090312111623200_dgaf288-B308","doi-asserted-by":"crossref","first-page":"e15044","DOI":"10.1111\/dme.15044","article-title":"Existing standardised questionnaires do not adequately capture quality-of-life outcomes of greatest importance for those living with type 1 diabetes in pregnancy","volume":"40","author":"Gu","year":"2023","journal-title":"Diabet Med"},{"issue":"2","key":"2025090312111623200_dgaf288-B309","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/dc10-1916","article-title":"Breastfeeding in women with type 1 diabetes: exploration of predictive factors","volume":"34","author":"Sparud-Lundin","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"2025090312111623200_dgaf288-B310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1471-6712.2008.00614.x","article-title":"Diabetes and pregnancy: women's opinions about the care provided during the childbearing year","volume":"23","author":"Anderberg","year":"2009","journal-title":"Scand J Caring Sci"},{"issue":"3","key":"2025090312111623200_dgaf288-B311","doi-asserted-by":"crossref","first-page":"101579","DOI":"10.1016\/j.wombi.2024.01.005","article-title":"Diabetes in pregnancy: women's views of care in a multi-ethnic, low socioeconomic population with midwifery continuity-of-care","volume":"37","author":"Bradford","year":"2024","journal-title":"Women Birth"},{"issue":"1","key":"2025090312111623200_dgaf288-B312","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12884-023-05542-4","article-title":"Understanding the self-management experiences and support needs during pregnancy among women with pre-existing diabetes: a qualitative descriptive study","volume":"23","author":"Sushko","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"2025090312111623200_dgaf288-B313","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/GRF.0000000000000759","article-title":"Improving postpartum and long-term health after an adverse pregnancy outcome: examining interventions from a health equity perspective","volume":"66","author":"Ditosto","year":"2023","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"2025090312111623200_dgaf288-B314","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/JPN.0000000000000399","article-title":"Continued disparities in postpartum follow-up and screening among women with gestational diabetes and hypertensive disorders of pregnancy: a systematic review","volume":"33","author":"Jones","year":"2019","journal-title":"J Perinat Neonatal Nurs"},{"key":"2025090312111623200_dgaf288-B315","volume-title":"The Complexities of Physician Supply and Demand: Projections From 2021 to 2036","author":"Colleges AoAM","year":"2024"},{"issue":"9","key":"2025090312111623200_dgaf288-B316","doi-asserted-by":"crossref","first-page":"bvae134","DOI":"10.1210\/jendso\/bvae134","article-title":"The arduous path toward equitable access to endocrinology care","volume":"8","author":"Romeo","year":"2024","journal-title":"J Endocr Soc"},{"key":"2025090312111623200_dgaf288-B317","volume-title":"AHRQ Comparative Effectiveness Reviews. Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis","author":"Saldanha","year":"2023"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf288\/63728294\/dgaf288.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/2405\/63728294\/dgaf288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/2405\/63728294\/dgaf288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T16:13:19Z","timestamp":1756915999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/2405\/8196670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,13]]},"references-count":317,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,7,13]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf288","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,13]]}}}